Revvity (RVTY) Stock Price
Revvity Price
Over the last 19 years Revvity grew revenue by 3.4% annually, reaching 2.86 B USD. Earnings per share have grown at 4.2% per year over the last 19 years. For Revvity, the net margin of 8.4% is down versus 24.6% a few years ago. At today's price the dividend yield works out to roughly 0.25%. The payout ratio is around 14% of earnings.
Revvity stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Revvity over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Revvity stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Revvity's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Revvity Price |
|---|
Revvity Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Revvity Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B USD) |
| NET INCOME (B USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e | 2031e |
|---|---|---|---|---|---|---|---|
| 2.76 | 2.86 | 3.04 | 3.19 | 3.37 | 3.62 | 3.86 | 4.39 |
| 0.18 | 3.67 | 6.34 | 5.1 | 5.67 | 7.41 | 6.46 | 13.74 |
| 55.79 | 54.76 | 51.5 | 49 | 46.37 | 43.17 | 40.55 | 35.65 |
| 1.54 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 |
| 0.27 | 0.24 | 0.62 | 0.69 | 0.76 | 0.85 | 0.95 | 1.14 |
| -61.04 | -10.74 | 158.51 | 10.91 | 10.13 | 11.7 | 11.18 | 20.11 |
| 0.28 | 0.28 | 0.14 | 0.75 | 0.81 | - | - | - |
| – | – | -50 | 435.71 | 8 | – | – | – |
| 122.82 | 116.6 | 116.6 | 116.6 | 116.6 | 116.6 | 116.6 | 116.6 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Revvity generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Revvity retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Revvity's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Revvity has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Revvity's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Revvity stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Revvity Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Revvity business model & stock analysis
Revvity SWOT Analysis
Strengths
1. Strong market presence: PerkinElmer Inc has established itself as a leading player in the scientific research and diagnostics sector, with a wide range of products and services.
2. Technological expertise: The company possesses advanced technologies and innovative solutions, giving it a competitive edge in the market.
3. Diversified product portfolio: PerkinElmer offers a diverse range of products across various segments, including life sciences, diagnostics, environmental testing, and food safety.
Weaknesses
1. Dependence on key customers: PerkinElmer relies heavily on a few large customers for a significant portion of its revenue, which exposes it to potential risks if any of these customers reduce their business or switch to competitors.
2. High research and development costs: Developing and maintaining advanced technologies requires substantial investments, which may strain the company's financial resources.
Opportunities
1. Growing demand for diagnostics: The increasing prevalence of diseases and the need for early detection and accurate diagnosis provide a significant growth opportunity for PerkinElmer in the diagnostics market.
2. Expansion in emerging markets: PerkinElmer can explore untapped markets in developing countries, leveraging its expertise to cater to the rising demand for scientific research and diagnostics solutions.
3. Acquisitions and partnerships: Strategic acquisitions or partnerships with complementary companies can help PerkinElmer expand its product offerings and broaden its customer base.
Threats
1. Intense competition: The scientific research and diagnostics market is highly competitive, with numerous established players and new entrants. PerkinElmer must continually innovate to stay ahead.
2. Regulatory challenges: Changes in regulations and compliance requirements can affect the company's operations, potentially leading to increased costs or barriers to market entry.
3. Economic downturns: Global economic uncertainties and recessions can impact the demand for PerkinElmer's products and services, as customers may reduce spending on research and diagnostics.
Revvity Eulerpool Fair Value
Revvity historical P/E ratio, EBIT multiple, and P/S ratio
Revvity annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Revvity shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Revvity Dividend History
37 years of dividend payments
Revvity dividend history and estimates
Max
Details
Revvity dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Revvity Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/5/2026 | 1.04USD | 717.86 MUSD | 2026 Q1 |
| 4/27/2026 | 1.04USD | 716.89 MUSD | 2026 Q1 |
| 2/2/2026 | 1.58USD | 776.64 MUSD | 2025 Q4 |
| 1/29/2026 | 1.58USD | 776.64 MUSD | 2025 Q4 |
| 5/9/2024 | 1.04USD | 660.53 MUSD | 2024 Q1 |
| 2/12/2024 | 1.17USD | 683.14 MUSD | 2023 Q4 |
EESG©
Eulerpool ESG Scorecard© for the Revvity stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Revvity shareholder structure
| % | Name |
|---|---|
19.96993% | |
12.37557% | |
6.87991% | |
6.36948% | |
5.98841% | |
5.12238% |
Revvity Executives and Management Board
Dr. Prahlad Singh
(60)President, Chief Executive Officer, Director · since 2016
Mr. Joel Goldberg
(56)Senior Vice President - Administration, General Counsel, Secretary
Mr. Maxwell Krakowiak
(35)Chief Financial Officer, Senior Vice President
Ms. Miriame Victor
(44)Chief Commercial Officer, Senior Vice President
Mr. Tajinder Vohra
(59)Senior Vice President - Global Operations
Frequently asked questions about Revvity
PerkinElmer Inc. is a company that focuses on providing products and services in the fields of diagnostics, life sciences, and applied services. Their business model revolves around offering innovative solutions for the healthcare and scientific community. With a wide range of product offerings, including instruments, reagents, consumables, software, and services, PerkinElmer Inc. aims to support scientific research, drug discovery, and diagnostics. By leveraging their expertise in detecting and analyzing biological and environmental challenges, the company strives to enable its customers to improve human and environmental health. PerkinElmer Inc.'s commitment to delivering advanced solutions makes it a trusted partner in the life sciences industry.
Revvity stock
Revvity Peer Group
Revvity Ticker
Revvity FIGI
All fundamentals and in-depth analysis of Revvity
Our stock analysis for Revvity Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Revvity Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.